By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Allergan plc 

U.S. Administrative Headquarters
Morris Corporate Center III, 400 Interpace Parkway
Parsippany  New Jersey  07054  U.S.A.
Phone: 862-261-7000 Fax: n/a


SEARCH JOBS

Allergan plc (AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.

Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry.

We’re Looking for the World’s Best

At Allergan, we are committed to recruiting and retaining the industry’s best and brightest employees and are proud to offer opportunities for military veterans at all levels across our company. We offer business, scientific, technical, engineering, sales & marketing and a variety of other positions here in the U.S. and around the world.

At Allergan, you will find an entrepreneurial style work environment where employees and employee teams are encouraged to apply their unique talents to grow, contribute, innovate and excel. We welcome your ideas. We provide the support, resources and encouragement that enable you to take your career to new heights. We focus on challenging you, challenging ourselves and driving success.

Commit to your future and join us. Learn more about our exciting career opportunities at www.allergan.com/careers.


Key Statistics


Email:
Ownership: Public

Web Site: Allergan
Employees:
Symbol: AGN
 



Industry
Pharmaceutical


Collaborations

Elan Pharmaceuticals 

CeNes Pharmaceuticals (U.S.) 

PanVera LLC 

Pharmagene Laboratories Limited  Phase ZERO(TM) products and services.

Acadia  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Acadia  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Acadia  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.





Company News
Cardiome Pharma Corp. (COM.TO) And Allergan (AGN) Announce XYDALBA (Dalbavancin) Licensing Agreement In International Markets 5/6/2016 7:41:25 AM
Allergan (AGN) Presents Data At The 2016 American Society of Cataract & Refractive Surgery Symposium & Congress In New Orleans 5/4/2016 9:13:23 AM
Allergan (AGN) Presents New Data At The American Urological Association Meeting In San Diego 5/3/2016 9:26:11 AM
Perrigo (PRGO) And Allergan (AGN) Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex 1200mg DM Extended-Release Tablets 5/3/2016 7:31:29 AM
Allergan (AGN) Launches Bold Initiative To Help U.S. Military Servicewomen Access LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 Mg At Military Treatment Facilities 5/2/2016 10:18:01 AM
Allergan (AGN) Receives FDA Approval And Launches First Generic Version Of CRESTOR (Rosuvastatin) 5/2/2016 6:04:02 AM
Allergan (AGN) Receives CHMP Positive Opinion For ENZEPI (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI) 4/29/2016 7:29:49 AM
Allergan (AGN) Finally Breaks Ground on $200 Million Texas Expansion, Facility to Up Headcount by 100 4/26/2016 6:05:04 AM
Allergan (AGN) Makes Another Deal, Bags Boston's Topokine for $85 Million+ 4/21/2016 3:05:35 PM
Biogen (BIIB), Regeneron (REGN) and Valeant (VRX) Rank High as Potential Takeover Targets for Allergan (AGN) 4/21/2016 7:27:42 AM
12345678910...
//-->